Back to today’s briefing

Story perspectives

FDA Questions Efficacy of Popular Decongestant Amid Placebo Debate

1/15/2025

34 4

Summary

Story summary

The FDA is re-evaluating phenylephrine, a widely used decongestant, after an advisory committee revealed it performs no better than a placebo. This revelation ignites a debate on the power of belief in healing, as studies indicate that placebos can genuinely alleviate cold symptoms, particularly in children.

1 of 1

Story summary

The FDA is re-evaluating phenylephrine, a widely used decongestant, after an advisory committee revealed it performs no better than a placebo. This revelation ignites a debate on the power of belief in healing, as studies indicate that placebos can genuinely alleviate cold symptoms, particularly in children.